INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SEC FORM 4/Option exerciseVerified data

Budur Kumar reported HRMY

CHIEF MEDICAL OFFICER · Harmony Biosciences Holdings, Inc. · Common Stock

Side
M
Value
—
Shares
18.8K
Price
—
Executed
May 1, 2026
Disclosed
May 18, 2026
Disclosure timeline17 days from execution to publication · legal deadline 2 business days
May 1 executedMay 18, 2026 disclosed

HRMY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
31/ 100 · ELEVATED
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+13 / 25

    No reported dollar value · 131.6% of prior position

  • Filing timing+10 / 15

    Disclosed 11 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HRMY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$27K
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    20
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$770K
    25.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    24
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$77K
    1,800 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    35
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$1.54M
    35.9K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    14
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    10.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$12K
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    21
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$34K
    800 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    20
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$319K
    10.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    5
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$12K
    400 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    14
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    25.4K sh
    		Sep 18, 2026Sep 18, 2026
    traded Sep 18, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$28K
    900 sh
    		Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    		+2dSEC FORM 4

    Evidence

    28
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$190K
    4,500 sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    19
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M$326K
    10.8K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    17
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    12.2K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    13
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Option exercise
    		M—
    10.8K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    35
    BK
    Budur KumarCHIEF MEDICAL OFFICER
    HRMYHarmony Biosciences Holdings, Inc.
    Open-market sale
    		SELL$989K
    23.0K sh
    		Sep 8, 2026Sep 9, 2026
    traded Sep 8, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002009762-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 1, 2026
    Published
    May 18, 2026
    Ingested by INSIDER
    Nov 5, 03:58 UTC
    Last re-read
    Nov 5, 03:58 UTC

    Extracted facts

    Filer
    Budur Kumar
    Role
    CHIEF MEDICAL OFFICER
    Transaction
    Option exerciseAs filed: “M”
    Asset
    Harmony Biosciences Holdings, Inc.
    Ticker
    HRMY
    Shares
    18.8K
    Price per share
    $0
    Execution date (reported)
    May 1, 2026
    Owned after transaction
    33.0K shares
    Days from execution to publication
    17

    What this establishes

    Budur Kumar filed this Form 4 reporting a option exercise of HRMY on May 1, 2026. It became public on May 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CHIEF MEDICAL OFFICER
    Budur Kumarcik:0002009762
    Issuer
    Harmony Biosciences Holdings, Inc.cik:0001802665

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.